Cyclo Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cyclo Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Cyclo Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 14, 2024 was 28.7M shares, a 48.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 28.7M +9.39M +48.6% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 28.7M +18.2M +172% Mar 15, 2024 10-K/A 2024-04-29
Q3 2023 22.7M +14.3M +168% Nov 13, 2023 10-Q 2023-11-14
Q2 2023 19.3M Aug 11, 2023 10-Q 2023-08-14
Q1 2023 10.6M +2.15M +25.6% Mar 31, 2023 10-K/A 2023-05-01
Q3 2022 8.48M Nov 10, 2022 10-Q 2022-11-10
Q1 2022 8.41M +2.11M +33.6% Mar 10, 2022 10-K 2022-03-11
Q4 2021 6.46M Nov 15, 2021 10-Q 2021-11-15
Q2 2021 6.44M -135M -95.5% Aug 13, 2021 10-Q 2021-08-16
Q1 2021 6.29M -115M -94.8% Mar 12, 2021 10-K 2021-03-12
Q3 2020 170M +48.8M +40.2% Nov 13, 2020 10-Q 2020-11-12
Q2 2020 142M +20.6M +17.1% Aug 14, 2020 10-Q 2020-08-14
Q1 2020 122M +30.4M +33.3% Mar 15, 2020 10-K 2020-03-30
Q3 2019 121M +33.5M +38.2% Nov 14, 2019 10-Q 2019-11-14
Q2 2019 121M +33.3M +37.9% Aug 13, 2019 10-Q 2019-08-13
Q1 2019 91.3M +17.8M +24.2% Mar 11, 2019 10-K 2019-03-15
Q3 2018 87.7M +14.6M +20% Nov 9, 2018 10-Q 2018-11-09
Q2 2018 87.7M +14.6M +20% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 73.5M +797K +1.1% Apr 10, 2018 10-K 2018-04-16
Q3 2017 73.1M +6.15M +9.19% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 73.1M +6.33M +9.48% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 72.7M +13.9M +23.7% Mar 1, 2017 10-K 2017-03-17
Q3 2016 67M +8.18M +13.9% Nov 10, 2016 10-Q 2016-11-10
Q2 2016 66.8M +9.3M +16.2% Aug 11, 2016 10-Q 2016-08-12
Q1 2016 58.8M +4.21M +7.72% Mar 17, 2016 10-K 2016-03-30
Q3 2015 58.8M +4.29M +7.87% Nov 9, 2015 10-Q 2015-11-12
Q2 2015 57.5M +3.09M +5.68% Aug 11, 2015 10-Q 2015-08-14
Q1 2015 54.6M +6M +12.4% Mar 25, 2015 10-K 2015-03-27
Q3 2014 54.5M +16.9M +45.1% Nov 10, 2014 10-Q 2014-11-14
Q2 2014 54.4M +17.4M +47% Aug 12, 2014 10-Q 2014-08-14
Q1 2014 48.6M +11.6M +31.3% Mar 3, 2014 10-K 2014-03-04
Q3 2013 37.6M Nov 12, 2013 10-Q 2013-11-13
Q2 2013 37M +314K +0.86% Aug 7, 2013 10-Q 2013-08-14
Q1 2013 37M +314K +0.86% Mar 11, 2013 10-K 2013-03-14
Q4 2012 36.7M Nov 30, 2012 10-Q 2012-11-13
Q2 2012 36.7M +1.17M +3.28% Aug 13, 2012 10-Q 2012-08-14
Q1 2012 36.7M Mar 15, 2012 10-K 2012-03-16
Q3 2011 36M Nov 10, 2011 10-Q/A 2012-02-23
Q2 2011 35.5M Aug 11, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.